Meningeal relapse in a case of B acute lymphoblastic leukemia: The role of CD56 expression

Medical Science Monitor

Volumn 15, Issue 2, 2009, Pages

  Cannizzo, Elisa ^a,b   Carulli, Giovanni ^a   Buda, Gabriele ^a   Zucca, Alessandra ^a   Azzara, Antonio ^a   Orciuolo, Enrico ^a   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Acute lymphoblastic leukemia; CD56; CNS relapse; Flow cytometry

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CD79A ANTIGEN; CD79B ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; BONE MARROW BIOPSY; CASE REPORT; CELL INFILTRATION; CEREBROSPINAL FLUID; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; LABORATORY TEST; LEUKEMIA RELAPSE; MENINX DISORDER; B LYMPHOCYTE; MENINX; METABOLISM; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE;

ANTIGENS, CD56; B-LYMPHOCYTES; FEMALE; HUMANS; MENINGES; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE;

EID: 63449137270     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Szczepanski T, van der Velden VHJ, van Dongen JJM: Classification systems for acute and chronic leukaemias. Best Practice Res Clin Haematol, 2003; 16: 561-82
2. Preti HA, Huh YO, O'Brien SM et al: Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis. Cancer, 1995; 76: 1564-70
3. Rutishauser U, Acheson A, Hall AK et al: The neural cell adhesion molecule NCAM) as a regulator of cell-cell interactions. Science, 1988; 240: 53-57
4. Cunningham BA, Hemperly JJ, Murray BA et al: Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science, 1987; 236: 799-806
5. Ikushima S, Yoshihara T, Matsumura T et al: Expression of CD56/N-CAM on hematopoietic malignant cells. A useful marker for acute monocyt- ic and megakaryocytic leukemias. Int J Hematol, 1991; 54: 395-403
6. Ferrara F, Morabito F, Martino B et al: CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. J Clin Oncol, 2000; 18(6): 1295-300
7. San Miguel JF, Gutierrez NC, Mateo G, Orfao A: Conventional diagnostics in multiple myeloma. Eur J Cancer, 2006; 42: 1510-19
8. Hashiguchi T, Tara M, Niina K et al: Adult T-cell Leukemia (ATL) cells which express neural cell adhesion molecule (NCAM) and infiltrate into the Central Nervous System. Internal Medicine, 2002; 41: 34-38
9. Ravandi F, Cortes J, Estrov Z et al: CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leukemia Research, 2002; 26: 643-49
10. Kantarjian HM, Thomas D, O'Brien S et al: Long-Term Follow-up Results of Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone (Hyper-CVAD), a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia. Cancer, 2004; 101: 2788-801
11. Guglielmi C, Cordone I, Boecklin F et al: Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications. Leukemia, 1997; 11: 1501-7
12. Tomova A, Babusikova O: Shift in expression of immunological cell markers in relapsed acute leukemia. Neoplasma, 2001; 48: 164-68
13. Zocchi MR, Vidal M, Poggi A: Involvement of CD56/N-CAM molecule in the adhesion of human solid tumor cell lines to endothelial cells. Exp Cell Res, 1993; 204: 130-35
14. Chang H, Brandwein J, Yi Qi-Long et al: Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leukemia Res, 2004; 28: 1007-11